ASPG and acute lymphoblastic leukemia: These results support the notion of the stability of this enzyme and its efficient glutaminase-free asparaginase activity, highlighting its potential as a viable alternative for the treatment of ALL in cases where patients are hypersensitive to ammonium production or have already generated an immune response to currently used asparaginases.